showed numerous spirochetes, which prompted a rereview and careful analysis of the slides, during which spirochetes were infrequently seen. PCR and sequencing of the 16S rRNA gene, performed as previously described, from a whole blood sample identifi ed these bacteria as B. persica (1) .
According to current recommendations in France, the patient was given doxycycline, 200 mg/d, for 10 days. During the fi rst 12 hours, he was monitored for a Jarish-Herxheimer reaction, which was not observed. By the end of therapy, infl ammatory syndrome and lymphopenia had resolved.
Despite high-level sequence conservation, identifi cation of Borrelia spp. by sequencing the 16S rRNA gene is reliable and useful for clinical practice (1, (4) (5) (6) . The sequence obtained from the patient reported here was identical (100% identity over 1,472 bp) to the B. persica HM161645 reference sequence available from GenBank and sampled from the Galilee region of Israel. It differed by 2 nt (99.86% identity) from B. persica U42297 and another unpublished sequence (B. persica 11/95), each from Iran. B. persica 11/95 was obtained from blood from a rodent collected in Iran and examined at the Institut Pasteur of Iran. We submitted the 2 B. persica sequences (1 from the patient reported here and 1 from the 11/95 sample) to GenBank (accession nos. HQ610930 and HQ610931, respectively). We confi rmed identifi cation of B. persica from the patient reported here by sequencing of both fl aB and intergenic spacer domains (data not shown), as described (7, 8) .
Although recently reviewed, the epidemiology of TBRF in the area of the former Union of Soviet Socialist Republics has not been extensively described (3) . In most of these countries, the infection is mainly attributed to B. persica and transmitted by Ornithodoros tholozani ticks, which live in caves, soil, wall crevices, houses, and cow sheds. 
